SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PTC Therapeutics -- PTCT
PTCT 68.30+0.3%Oct 31 3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche10/16/2014 7:28:04 PM
1 Recommendation

Recommended By
sjemmeri

   of 38
 
>> The previously announced underwritten public offering of 3,450,000 shares of common stock of PTC Therapeutics, Inc. (the “Company”), including 450,000 shares issued upon exercise by the underwriters of their option to purchase additional shares, closed on October 16, 2014. The Company expects its net proceeds from this offering to be approximately $117.5 million, after deducting the underwriting discounts and commissions and estimated expenses payable by the Company. <<

Priced at $36.25/share, closed today at 37.55. Company had $227m in the bank, end of 2Q. Burn was $25m for the quarter.

Go Giants!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News